NINGBO INNO PHARMCHEM CO.,LTD. is proud to highlight the importance of Methyl 4-Methyl-3-((4-(Pyridin-3-yl)Pyrimidin-2-yl)Amino)Benzoate (CAS: 917392-54-2), a crucial pharmaceutical intermediate that plays a pivotal role in the synthesis of Nilotinib Hydrochloride Monohydrate. This compound is indispensable for the treatment of Chronic Myelogenous Leukemia (CML), a condition that significantly impacts patients' quality of life. Our commitment lies in providing high-purity materials that enable the production of life-saving medications.

The synthesis of advanced therapeutics like Nilotinib relies heavily on the quality and consistency of its precursors. Methyl 4-Methyl-3-((4-(Pyridin-3-yl)Pyrimidin-2-yl)Amino)Benzoate, often referred to as a key pharmaceutical intermediate, is no exception. Its characterization includes an off-white to light yellow crystalline powder appearance and a high assay of ≥99.0% via HPLC. These attributes are crucial for ensuring that the final drug product meets stringent regulatory standards and therapeutic efficacy requirements. The consistent quality of this high purity chemical compound directly translates to the safety and effectiveness of the CML treatment.

Understanding the chemical and physical properties of this molecule is paramount for effective utilization in pharmaceutical manufacturing. With a density of 1.3±0.1 g/cm³ and a boiling point of 538.6±60.0 °C at 760 mmHg, the compound exhibits robust thermal stability. Its low vapor pressure and high flash point also contribute to its safe handling and processing in industrial settings. These properties underscore why it is a preferred choice when seeking a pharmaceutical manufacturing chemical or a tyrosine kinase inhibitor precursor. NINGBO INNO PHARMCHEM CO.,LTD. ensures that the supply chain for this vital compound is reliable, allowing pharmaceutical companies to focus on their core manufacturing processes.

The significance of Methyl 4-Methyl-3-((4-(Pyridin-3-yl)Pyrimidin-2-yl)Amino)Benzoate extends beyond its chemical specifications; it is a cornerstone in the development of targeted cancer therapies. As a Nilotinib hydrochloride monohydrate precursor, it directly contributes to the availability of a drug that has transformed CML treatment paradigms. The advancements in fine chemical engineering that allow for the consistent production of such high-purity intermediates are a testament to the industry's progress. For those seeking a reliable source for this compound, understanding its application in cancer therapy intermediate development is key.

NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supporting the pharmaceutical industry by providing essential chemical building blocks. Our role as a provider of high-quality Nilotinib synthesis intermediates allows our partners to accelerate their API development projects effectively and economically. We are committed to maintaining rigorous quality control throughout our operations, ensuring that every batch of Methyl 4-Methyl-3-((4-(Pyridin-3-yl)Pyrimidin-2-yl)Amino)Benzoate meets the highest industry standards. This dedication is vital for the advancement of medical treatments and patient well-being.